PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lantz E et al. – The ability to probe diseases at the genomic level has improved our understanding and enhanced the treatment of breast cancer. One important finding relates to the HER2 oncogene which encodes a novel transmembrane receptor that, when overexpressed, appears to confer growth and survival advantages to breast tumor cells. This fortuitous discovery enabled researchers to develop agents which could inhibit receptor–mediated tumor cell signaling. Numerous clinical trials of such agents have demonstrated improved outcomes in patients with HER2–positive breast cancer. Nonetheless, not all tumors respond to therapy targeting the receptor, while relapses occur after an initial response to treatment. This paper provides a historical and current perspective of the treatment of patients with HER2–positive breast cancer.

   

Related Articles

Genetic Variation in the Progesterone Receptor and Metabolism Pathways and Hormone Therapy in Relation to Breast Cancer Risk
American Journal of Epidemiology, 10/22/09    Relevance Score: 80%

Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer
Breast Cancer Research and Treatment, 11/12/09    Relevance Score: 71%

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09    Relevance Score: 70%

Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1
Breast Cancer Research and Treatment, 10/29/09    Relevance Score: 69%

Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility
BMC Cancer, 10/09/09    Relevance Score: 68%

Today in Hematology/Oncology...keeping you current

Intraspinal techniques for pain management in cancer patients: a systematic review
Supportive Care in Cancer, 12/04/09

Anemia in Adults With Congenital Heart Disease Relates to Adverse Outcome
JACC - Journal of the American College of Cardiology, 12/04/09

Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
European Urology, 12/04/09

Today in Women`s Health...keeping you current

Adjuvant Phytotherapy in the Treatment of Cervical Cancer: A Systematic Review and Meta-Analysis
Journal of Alternative and Complementary Medicine, 12/04/09

Coronary heart disease and menopause management: The swinging pendulum of HRT
Atherosclerosis, 12/04/09

Socioeconomic Factors and Vitamin A Status of Pregnant Women in Calabar Urban, Southeastern Nigeria
Maternal and Child Health Journal , 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address